[{"indications": "Indications\u00a0aerobic and anaerobic Gram-positive and Gram-negative infections\r\n(\n(From 5.1.2.2 Carbapenems: British National Formulary)\n5.1.2.2 Carbapenems); hospital-acquired septicaemia\r\n(Table 1, %s\n(From Blood: British National Formulary)\nBlood)", "name": "MEROPENEM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.2 Cephalosporins, carbapenems, and other beta-lactams", "5.1.2.2 Carbapenems", "MEROPENEM"], "cautions": "Cautions\u00a0sensitivity to beta-lactam antibacterials (avoid if history of immediate hypersensitivity reaction, see Hypersensitivity Reactions); interactions: Appendix 1 (meropenem)", "side-effects": "Side-effects\u00a0nausea, vomiting, diarrhoea (antibiotic-associated\r\ncolitis reported), abdominal pain, disturbances in liver function\r\ntests, headache, thrombocythaemia, rash, pruritus; less commonly paraesthesia, eosinophilia, thrombocytopenia, leucopenia; rarely convulsions; also reported haemolytic anaemia, positive\r\nCoombs\u2019 test, Stevens-Johnson syndrome, toxic epidermal necrolysis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/33502.htm", "doses": ["By intravenous injection over 5 minutes or by intravenous infusion, 0.5\u20131\u00a0g every\r\n8 hours; child 3 months\u201312 years 10\u201320\u00a0mg/kg\r\nevery 8 hours, body-weight over 50\u00a0kg, adult dose", "Exacerbations of chronic lower respiratory-tract infection in\r\ncystic fibrosis, meningitis, 2\u00a0g every 8 hours; child 3 months\u201312 years 40\u00a0mg/kg every 8 hours, body-weight over 50\u00a0kg,\r\nadult dose"], "pregnancy": "Pregnancy\u00a0use only if potential benefit outweighs risk\u2014no information\r\navailable"}]